This webinar, “Personalized Pathways to Long-term Survival in EGFRm NSCLC,” will update clinicians on how to optimize treatment sequencing to extend survival in EGFR-mutant NSCLC. The program will first review evolving long-term survival goals, then focus on the role of chemotherapy in daily practice, including its use after progression on first-line TKIs and its integration with subsequent treatments to achieve long-term overall survival. Through expert lectures and a panel discussion, participants will learn practical strategies to design individualized, evidence-based treatment pathways and improve long-term patient outcomes.